News & Updates

Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
19 Jun 2022

In rheumatoid arthritis-related interstitial lung disease (RA-ILD), change over time in the levels of serum proteins, such as matrix metallopeptidase 13 (MMP13) and C-X-C motif ligand chemokine 11 (CXCL11), predict clinical outcomes, a recent study has found. The same is true for baseline clinical factors such as patient age and rheumatoid factor.

Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
19 Jun 2022
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
19 Jun 2022